Work

Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium

Year: 2010

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-010-9420-8

Authors: Deborah A. Bradley, Stephanie Daignault, Charles J. Ryan, Robert S. DiPaola, David C. Smith, Eric Small, Mitchell E. Gross, Mark N. Stein, Alice Chen, Maha Hussain

Institutions: Duke University, University of Michigan, University of California, San Francisco, Rutgers Cancer Institute, Cedars-Sinai Medical Center, National Institutes of Health, Michigan Medicine, U-M Rogel Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Merck KGaA, National Cancer Institute

Award: G2585515454

OpenAlex ID: W2083294486

FWCI: 5.895

Cites: 49

Cited by: 60

Related to: 10